Davis Advantage forPsychiatricMentalHealth Nursing Karyn
cf cf cf cf cf cf cf
cf I. Morgan
cf
11thEdition
cf
, Table of Contents c f c f
Chapter 01. The Concept of Stress Adaptation
cf cf cf c f cf c f
Chapter 02. Mental Health/Mental Illness: Historical and Theoretical
cf cf cf cf cf cf cf
Concepts
cf
Chapter 03. Psychopharmacology
c f c f
Chapter 04. Concepts of Psychobiology
cf cf cf cf cf
Chapter 05. Ethical and Legal Issues in Psychiatric/Mental Health Nursing
cf c f cf c f cf c f cf c f cf
Chapter 06. Cultural and Spiritual Concepts Relevant to Psychiatric/Mental Health
c f c f c f c f c f c f c f c f c f
Nursing Chapter 07. Relationship Development
c f cf c f c f c f
Chapter 08. Therapeutic Communication
cf cf c f
Chapter 09. The Nursing Process in Psychiatric/Mental Health Nursing
cf cf cf cf cf cf cf cf
Chapter 10. Therapeutic Groups
cf c f c f c f
Chapter 11. Intervention With Families
c f c f c f c f
Chapter 12. Milieu Therapy - The Therapeutic Community
cf cf cf cf cf cf cf
Chapter 13. Crisis Intervention
cf c f c f c f
Chapter 14. Assertiveness Training
cf cf cf
c Chapter 15. Promoting Self-Esteem
f cf cf cf
c Chapter 16. Anger/Aggression
f cf cf
Management Chapter 17. The Suicidal
cf cf c f c f c f
Client
c f
Chapter 18. Behavior Therapy
c f c f c f
Chapter 19. Cognitive Therapy
cf c f c f c f
Chapter 20. Electroconvulsive
cf cf cf
Therapy Chapter 21. The
cf c f c f c f
Recovery Model Chapter 22.
c f cf c f c f
Neurocognitive Disorders
c f cf
Chapter 23. Substance-Related and Addictive Disorders
c f c f c f c f c f
Chapter 24. Schizophrenia Spectrum and Other Psychotic Disorders
cf cf cf cf cf cf cf
Chapter 25. Depressive Disorders
cf c f c f c f
Chapter 26. Bipolar and Related Disorders
c f c f c f c f c f
Chapter 27. Anxiety, Obsessive-Compulsive, and Related Disorders
cf cf cf cf cf cf
Chapter 28: Trauma and Stressor-Related Disorders
cf c f c f c f c f c f
Chapter 29. Somatic Symptom and Dissociative Disorders
c f c f c f c f c f c f
Chapter 30. Issues Related to Human Sexuality and Gender Dysphoria
cf cf cf cf cf cf cf cf cf
Chapter 31. Eating Disorders
cf c f c f c f
Chapter 32. Personality Disorders
c f c f c f
Chapter 33. Children and Adolescents
cf cf cf cf cf
Chapter 34. The Aging Individual
cf c f c f c f c f
Chapter 35. Survivors of Abuse or Neglect
c f c f c f c f c f c f
Chapter 36. Community Mental Health Nursing
cf cf cf cf cf cf
Chapter 37. The Bereaved Individual
cf c f c f c f c f
Chapter 38. Military Families
c f c f c f
,Chapter 01. Psychopharmacology c f c f
Multiple Choice cf
1. The NURSE manager on the psychiatric unit was explaining to the new staff the
cf c f c f c f c f c f c f cf c f c f c f c f c f
differences between typical and atypical antipsychotics. The NURSE correctly states
c f cf c f c f c f c f c f c f c f c f
that atypical antipsychotics:
c f c f cf
A. Remain in the system longer c f c f c f c f
B. Act more quickly to reduce delusions
cf cf c f cf c f
C. Produce fewer extrapyramidal effects c f c f c f
D. Are risk free for neuroleptic malignant syndrome (NMS)
c f c f c f c f c f c f c f
CORRECTqANSWER:C cf
Atypical antipsychotics produce less D2blockade; thus movement disorders are less of a
c f c f c f c f c f c f c f c f c f c f c f
problem. No evidence suggests that the medication remains in the system longer nor that it acts more
c f c f cf cf cf cf cf cf cf cf cf cf cf cf cf cf cf
quicklyto reduce delusions. The atypicals are not risk free for NMS.
cf cf cf c f c f c f c f c f c f c f c f
KEY: Cognitive Level: Application | Integrated Processes: Nursing Process: Implementation | Client
cf c f c f c f cf c f c f c f c f c f cf
Need:
c f
Physiological Integrity: Pharmacological and Parenteral Therapies
cf c f c f cf c f
2. The NURSE would assess for neuroleptic malignant syndrome (NMS) if a
cf c f c f c f c f c f c f c f c f c f
patient on haloperidol (Haldol) develops a:
c f c f cf c f c f c f
A. 30 mm Hg decrease in blood pressure reading
c f c f c f c f c f c f c f
B. Respiratory rate of 24 respirations per minute c f c f c f c f c f c f
C. Temperature reading c f c f of 104° F c f c f
D. Pulse rate of 70 beats per minute
c f c f c f c f c f c f
CORRECTqANSWER:C cf
Increased temperature is the cardinal sign of NMS. This BP is not a significant feature of
c f c f c f c f c f c f c f cf c f c f c f c f c f c f c f
NMS. There are no significant findings to support the options related to respirations or pulse
c f c f c f cf c f c f c f c f c f c f c f c f c f c f c f
rate.
c f
KEY: Cognitive Level: Application | Integrated Processes: Nursing Process: Assessment | Client
cf c f c f c f cf c f c f c f cf c f cf
Need:
c f
Physiological Integrity: Pharmacological and Parenteral Therapies
cf c f c f cf c f
3. A patient taking fluphenazine (Prolixin) complains of dry mouth and blurred vision. What
c f c f c f c f c f c f c f c f c f c f c f c f
would the NURSE assess as the likely cause of these symptoms?
c f c f cf c f c f c f c f c f c f c f c f
A. Decreased dopamine at receptor sites c f c f c f c f
B. Blockade of histamine cf cf
C. Cholinergic blockade c f
D. Adrenergic blocking c f
CORRECTqANSWER:C cf
Fluphenazine administration produces blockade of cholinergic receptors giving rise to
c f c f cf cf c f c f c f c f c f
, cf anticholinergic effects, such as dry mouth, blurred vision, and constipation.
cf c f c f c f c f c f c f c f c f
KEY: Cognitive Level: Application | Integrated Processes: Nursing Process: Assessment | Client
cf c f c f c f cf c f c f c f cf c f cf
Need:
c f